1Neil A Castle. Aquaporins as targets for drug discovery. Drug Discovery Today, 2005,10(7) : 485.
2Nielsen S. Renal aquaporins: an overview. BJU International, 2002,90(Suppl 3) : 1 - 6.
3Fushimi K, Uchida S, Hara Y, et al. Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature, 1993,361(6412) : 549 - 552.
4Kim SW, Jeon YS, Lee JU, et al. Diminished adenylate cyclase activity and aquaporin 2 expression in acute renal failure rats. Kidney Int,2000,57(4) : 1643 - 1650.
5Nielsen S, Frokiaer J, Marples D, et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev, 2002,82 ( 1 ) : 205 - 244.
6Nielsen S, Chou GL, Marples D, et al. Vasopression increases water permeability of kidney collecting duct by inducing translocaion of aquaporin - CD water channels to plasma membrane. Proc Natl Acad Sci USA, 1995,92(4) : 1013 - 1017.
7Yasni M, Marples D, Belusa R, et al. Development of urinary concentrating capacity, role of aquaporin- 2. Am J Phiol, 1996, 217(2 Pt 2) :461 - 468.
8Xu DL,Martin PY,Ohara M,et al. Upregulation of aquaporin - 2 water channel eExpression in chronic heart failure. J Clin Invest, 1997,99(7) : 1500 - 1505.
8George A. The microinflammatory state in uremia:causes and po- tential consequences [J]. J Am Soc Nephrol, 2001, 12 (7) : 1549 -1557.
9Stenvinkel P, Heimburger O, Pauhre F, et al. Strong association between malnutrition,inflammation, and atherosclerosis in chron- ic renal failure[J]. Kidney Int, 1999, 55(5) : 1899-1911.
10Nielsen S. Renal aquaporins: an overview [ J ]. BJU lnt, 2002, 90(suppl.3) : 145.
